脊髓损伤中的多药用药：匹配队列分析比较药物类别、医疗并发症和医疗利用指标及24个月随访

数据集获取（Figshare）

• 源站标题：Polypharmacy in spinal cord injury: Matched cohort analysis comparing drug classes, medical complications, and healthcare utilization metrics with 24-month follow-up
• DOI：10.6084/m9.figshare.26348522.v1
• 发布日期：2024-07-22
• 文件数：4 个
• 文件总体积：60.59 KB
• 源站页面：https://tandf.figshare.com/articles/dataset/Polypharmacy_in_spinal_cord_injury_Matched_cohort_analysis_comparing_drug_classes_medical_complications_and_healthcare_utilization_metrics_with_24-month_follow-up/26348522

命令行下载

curl -L -o "yscm_a_2375892_sm2084.docx" "https://ndownloader.figshare.com/files/47847395"
curl -L -o "yscm_a_2375892_sm2083.docx" "https://ndownloader.figshare.com/files/47847398"
curl -L -o "yscm_a_2375892_sm2082.docx" "https://ndownloader.figshare.com/files/47847401"
curl -L -o "yscm_a_2375892_sm2081.docx" "https://ndownloader.figshare.com/files/47847404"

文件清单

• yscm_a_2375892_sm2084.docx（15.01 KB）
• yscm_a_2375892_sm2083.docx（14.57 KB）
• yscm_a_2375892_sm2082.docx（15.61 KB）
• yscm_a_2375892_sm2081.docx（15.40 KB）

文件总体积 60.59 KB（源站 API 实测）。

数据说明

Polypharmacy in spinal cord injury (SCI) is common and predisposes patients to increased risk of adverse events. Evaluation of long-term health consequences and economic burden of polypharmacy in patients with SCI is explored.
Retrospective cohort.
The IBM Marketscan Research Databases claims-based dataset was queried to search for adult patients with SCI with a 2-year follow-up.
Two matched cohorts were analyzed: those with and without polypharmacy, analyzing index hospitalization, readmissions, payments, and health outcomes.
A total of 11 569 individuals with SCI were included, of which 7235 (63%) were in the polypharmacy group who took a median of 11 separate drugs over two years. Opioid analgesics were the most common medication, present in 57% of patients with SCI meeting the criteria of polypharmacy, followed by antidepressant medications (46%) and muscle relaxants (40%). Risk of pneumonia was increased for the polypharmacy group (58%) compared to the non-polypharmacy group (45%), as were urinary tract infection (79% versus 63%), wound infection (30% versus 21%), depression (76% versus 57%), and adverse drug events (24% versus 15%) at 2 years. Combined median healthcare payments were higher in polypharmacy at 2 years ($44 333 vs. $10 937, P Majority of individuals with SCI met the criteria for polypharmacy with nearly 60% of those prescribed opioids and taking drugs from high-risk side effect profiles. Polypharmacy in SCI was associated with a greater risk of pneumonia, depression, urinary tract infections, adverse drug events, and emergency room visits over two years with four times higher overall healthcare payments at 1-year post-injury.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.26348522.v1（source: https://tandf.figshare.com/articles/dataset/Polypharmacy_in_spinal_cord_injury_Matched_cohort_analysis_comparing_drug_classes_medical_complications_and_healthcare_utilization_metrics_with_24-month_follow-up/26348522）。